Request a Quote


Patient Travel and Reimbursements for AL Amyloidosis Study

This three-year rare disease study was being conducted at 75 study sites throughout the United States, Canada, Europe, and Australia. The study required a 13-month commitment from patients, and had a rigorous visit calendar for the first 3 months of treatment, thus the sponsor was seeking assistance with patient travel and coordination.

Please fill out the form on the right to review the case study.


Subscribe to our newsletter

For the latest news & resources, sign up for our monthly newsletter.

I am a

Thank you for subscribing!

Something wrong, please try again!

ClinEdge (en-US)// ClinEdge (en-US)Every Stage of Every Study. Creating innovative solutions that connect and empower the clinical trial ecosystemHomehttps://clin-edge.comCases